Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Farber

Showing results (101-110 of 176) with videos related to

Pageof 18
Sort By:
Scientific Reports|November 23, 2021
Dynamic changes in immune gene co-expression networks predict development of type 1 diabetesIngrid Brænne, Suna Onengut-Gumuscu, Ruoxi Chen, et al.
Journal of Musculoskeletal & Neuronal Interactions|September 1, 2021
Genetic variability affects the response of skeletal muscle to disuseCamilla Reina Maroni, Michael A Friedman, Yue Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Long-read proteogenomics to connect disease-associated sQTLs to the protein isoform effectors of diseaseAbdullah Abood, Larry D Mesner, Erin D Jeffery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up dataL R Prosnitz, L R Farber, D S Kapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2017
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale ExperienceAlan J Koletsky, Joseph R Bertino, Leonard R Farber, et al.
International Journal of Molecular Sciences|January 11, 2022
MicroRNA-30b Is Both Necessary and Sufficient for Interleukin-21 Receptor-Mediated Angiogenesis in Experimental Peripheral Arterial DiseaseTao Wang, Liang Yang, Mingjie Yuan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 21, 2020
Old Mice Have Less Transcriptional Activation But Similar Periosteal Cell Proliferation Compared to Young-Adult Mice in Response to in vivo Mechanical LoadingChristopher J Chermside-Scabbo, Taylor L Harris, Michael D Brodt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experienceA J Koletsky, J R Bertino, L R Farber, et al.
American Journal of Infection Control|May 1, 2012
Competency in infection prevention: a conceptual approach to guide current and future practiceDenise M Murphy, Marilyn Hanchett, Russell N Olmsted, et al.
Cancer Treatment Reports|June 1, 1982
Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphomaL N Newcomer, E C Cadman, M I Nerenberg, et al.
Pageof 18

Showing results (101-110 of 176) with videos related to

Sort By:
Pageof 18
Scientific Reports|November 23, 2021
Dynamic changes in immune gene co-expression networks predict development of type 1 diabetesIngrid Brænne, Suna Onengut-Gumuscu, Ruoxi Chen, et al.
Journal of Musculoskeletal & Neuronal Interactions|September 1, 2021
Genetic variability affects the response of skeletal muscle to disuseCamilla Reina Maroni, Michael A Friedman, Yue Zhang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Long-read proteogenomics to connect disease-associated sQTLs to the protein isoform effectors of diseaseAbdullah Abood, Larry D Mesner, Erin D Jeffery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up dataL R Prosnitz, L R Farber, D S Kapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2017
Second Neoplasms in Patients With Hodgkin's Disease Following Combined Modality Therapy-The Yale ExperienceAlan J Koletsky, Joseph R Bertino, Leonard R Farber, et al.
International Journal of Molecular Sciences|January 11, 2022
MicroRNA-30b Is Both Necessary and Sufficient for Interleukin-21 Receptor-Mediated Angiogenesis in Experimental Peripheral Arterial DiseaseTao Wang, Liang Yang, Mingjie Yuan, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 21, 2020
Old Mice Have Less Transcriptional Activation But Similar Periosteal Cell Proliferation Compared to Young-Adult Mice in Response to in vivo Mechanical LoadingChristopher J Chermside-Scabbo, Taylor L Harris, Michael D Brodt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1986
Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experienceA J Koletsky, J R Bertino, L R Farber, et al.
American Journal of Infection Control|May 1, 2012
Competency in infection prevention: a conceptual approach to guide current and future practiceDenise M Murphy, Marilyn Hanchett, Russell N Olmsted, et al.
Cancer Treatment Reports|June 1, 1982
Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphomaL N Newcomer, E C Cadman, M I Nerenberg, et al.
Pageof 18